Contributor content
Presentation
Late life echocardiographic effects of the amyloidogenic V142I transthyretin variant
Presentation
Cardiovascular burden of the amyloidogenic V1421 transthyretin variant in black individuals
Presentation
Age dependency of cardiovascular outcomes with the amyloidogenic p142I transthyretin variant among black individuals
Presentation
Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure with Reduced Ejection Fraction: DEFINE-HF
Presentation
Serum uric acid, influence of sacubitril/valsartan, and cardiovascular outcomes in heart failure with preserved ejection fraction: PARAGON-HF
Presentation


